Antibiotics Market

Antibiotics Market

Growth Factors of Antibiotics Market

The antibiotics market size was valued at USD 39.73 billion in 2023, and the market is now projected to grow from USD 40.66 billion in 2024 to USD 51.88 billion by 2032, exhibiting a CAGR of 3.1% during the forecast period of 2023-2030.

Due to restrictions on the transportation and disruption in the supply chain has hampered the manufacturing processes. Shutting down many manufacturing units and associated goods has affected the supply chain. There is scarcity of raw material and delay in the production of the products and components. The COVID-19 pandemic has influenced the antibacterial drugs prescription practices. Shifting the priorities for the medical sect has hindered the antibiotics market growth. The patients were reluctant to visit unnecessary healthcare settings.

The increasing rate of recurrence of bacterial contagion is impelling the antibiotics market share globally. The rising anxiety about growth of bacterial disease is opening avenues for expanding the market. It is probable to become the most common cause for lost life worldwide in the future. They are escalating necessities for the product and consequently increasing the revenue of the market.

The rising acquaintance of antibiotic resistance among the population is the market trend. This has directed the pharmaceutical and biopharmaceuticals business to raise focus on developing combination drugs. These drugs are in high demand as they will be used for additive and synergistic effects. The pharmaceutical manufacturers are trying to produce advanced blended therapies. Therefore, the customers are enhancing demand for the product and are propelling the market growth.

Comprehensive Analysis of Antibiotics Market

The antibiotics market and healthcare industry is increasing at an exponential rate owing to its market segmentation. This market expansion effectively provides a detailed regional assessment considering the dominant supply and demand forces that impact the pharmaceutical industry. These segmentations are methodically categorized by drug class, application, route of administration, and distribution channels. The drug class includes aminoglycosides, cephalosporin, fluoroquinolones, macrolides, penicillin, sulfonamides, tetracycline, and others. The applications involve gastrointestinal infections, skin infections, respiratory infections, urinary tract infections, septicemia, ear infection, and others. The distribution channels involve retail pharmacies, hospital pharmacies, and online pharmacies. The route of administration is estranged into oral, parenteral, and others.

The North American region is dominating the global antibiotics market leading to a recall of USD 17.91 billion due to the continuous progress in medical care facilities and high demand for these drugs are boosting the market enlargement in the region.

The top players in the market play a vital role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include Pfizer Inc. (U.S.), Abbott (U.S.), GlaxoSmithKline plc.(U.K.), Sanofi(France), Bayer AG (Germany), Bristol-Myers Squibb Company (U.S.), Merck & Co., Inc. (U.S.), Astellas Pharma Inc.(Japan), Novartis AG (Switzerland), and Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals, Inc.) (U.S.), these market players provide a level-playing competitive landscape.

In March 2024, Wockhardt announced that its investigational antibiotic under-trial drug, Zidebactam/Cefepime illustrated thriving results. This has been examined in treating a highly drug-resistant skull bone infection and pneumonia in a renal transplant patient.

Segmentation Table

Global Antibiotics Market Scope

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 3.1% from 2024-2032

Unit Value (USD billion)

Segmentation By Drug Class

- Penicillin

- Cephalosporin

- Aminoglycosides

- Tetracycline

- Macrolides

- Fluoroquinolones

- Sulfonamides

- Others

By Application

- Skin Infections

- Respiratory Infections

- Urinary Tract Infections

- Septicemia

- Ear Infection

- Gastrointestinal Infections

- Others

By Route of Administration

- Oral

- Parenteral

- Others

By Distribution Channel

- Hospital Pharmacy

- Retail Pharmacy

- Online Pharmacy

By Geography

- North America (By Drug Class, Application, Route of Administration, Distribution Channel, and Country)

- U.S.

- Canada

Europe (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)

- U.K.

- Germany

- France

- Italy

- Spain

- Scandinavia

- Rest of Europe

Asia-Pacific (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)

- Japan

- China

- India

- Australia

- Southeast Asia

- Rest of Asia Pacific

Latin America (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)

- Brazil

- Mexico

- Rest of Latin America

Middle East & Africa (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)

- GCC

- South Africa

- Rest of the Middle East & Africa


Please Note: It will take 5-6 business days to complete the report upon order confirmation.